VanEck Associates’s Ligand Pharmaceuticals LGND Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q1 | – | Sell |
-404
| Closed | -$26K | – | 898 |
|
|
2016
Q4 | $26K | Buy |
404
+199
| +97% | +$12.8K | ﹤0.01% | 860 |
|
|
2016
Q3 | $13K | Sell |
205
-109
| -35% | -$6.91K | ﹤0.01% | 854 |
|
|
2016
Q2 | $23K | Buy |
314
+30
| +11% | +$2.2K | ﹤0.01% | 827 |
|
|
2016
Q1 | $19K | Buy |
+284
| New | +$19K | ﹤0.01% | 805 |
|